Evidence map›Paper›PMID 35059314›Full record

ArticleFrontiers in oncology2021

Maria A Pantaleo, Milena Urbini, Angela Schipani, Margherita Nannini, Valentina Indio, Antonio De Leo, Bruno Vincenzi, Antonella Brunello, Giovanni Grignani, Mariaelena Casagrande and 13 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. To screen or not to screen: complexity ofEndocrine oncology (Bristol, England) · 2026
    Article
  2. Article
  3. Article
  4. A Novel Human SDHA-Knockout Cell Line Model for the Functional Analysis of Clinically Relevant SDHA Variants.Clinical cancer research : an official journal of the American Association for Cancer Research · 2024
    Article
  5. Review
  6. [Gastrointestinal stromal tumors : Where do we stand?]Pathologie (Heidelberg, Germany) · 2024
    Review
  7. Precision Oncology in Gastrointestinal Stromal Tumors.Current oncology (Toronto, Ont.) · 2023
    Review
  8. Genes · 2023
    Review
  9. [Abdominal soft tissue tumors].Pathologie (Heidelberg, Germany) · 2022
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 9 institutions in 1 country.

Maria A PantaleoDivision of Oncology, IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.
Milena Urbini"Giorgio Prodi" Cancer Research Center, University of Bologna, Bologna, Italy.
Angela SchipaniDepartment of Experimental, Diagnostic and Specialized Medicine, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Margherita NanniniDivision of Oncology, IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.
Valentina Indio"Giorgio Prodi" Cancer Research Center, University of Bologna, Bologna, Italy.
Antonio De LeoDepartment of Experimental, Diagnostic and Specialized Medicine, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Bruno VincenziDepartment of Medical Oncology, University Campus Bio-Medico, Rome, Italy.
Antonella BrunelloOncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV - IRCCS, Padova, Italy.
Giovanni GrignaniDivision of Medical Oncology, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy.
Mariaelena CasagrandeDepartment of Oncology , University and General Hospital, Udine, Italy.
Elena FumagalliDepartment of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Elena ConcaDepartment of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Maristella SaponaraMelano and Sarcoma Medical Treatment Unit, Istituto Europeo di Oncologia, Milan, Italy.
Elisa GruppioniDepartment of Pathology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Annalisa AltimariDepartment of Pathology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
Dario De BiaseAnatomic Pathology and Molecular Diagnostic Unit-University of Bologna Medical Center, Bologna, Italy.
Giovanni TalliniDepartment of Experimental, Diagnostic and Specialized Medicine, S.Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.
Gloria RavegniniDepartment of Pharmacy and Biotechnology (FaBit), University of Bologna, Bologna, Italy.
Daniela TurchettiUnit of Medical Genetics, IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.
Marco SeriUnit of Medical Genetics, IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.
Andrea ArdizzoniDivision of Oncology, IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.
Paola SecchieroDepartment of Translational Medicine, University of Ferrara, Ferrara, Italy.
Annalisa AstolfiDepartment of Translational Medicine, University of Ferrara, Ferrara, Italy.
University of Bologna · ITAzienda USL di Bologna · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITUniversity of Ferrara · ITCandiolo Cancer Institute · ITEuropean Institute of Oncology · ITIstituto Oncologico Veneto · ITUniversità Campus Bio-Medico · ITUniversity of Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSDH-

methodsGermline

resultsAll patients carried a germline

conclusion

Indexed as

CSS: Carney-Stratakis syndromeCT: Carney Triadgastrointestinal stromal tumorsSDHASDHA germinal mutationsSDH-deficient GIST

Identifiers

PMID35059314
PMCPMC8764450
OpenAlexW4205712629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.